• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012463-18
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 07/18/2016
Event Type  Death  
Manufacturer Narrative
(b)(4).The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
It was reported that on (b)(6) 2014, the patient underwent a coronary procedure with implantation of two absorb bioresorbable vascular scaffolds (bvs) in the proximal and mid right coronary artery (rca).On (b)(6) 2016, approximately 2 years later, the patient was found dead at home.Cause of death is unknown.No additional information provided.
 
Manufacturer Narrative
(b)(4).Although the patient death, due to ischemic heart disease and right coronary artery atheroma, is not related to the implanted absorb scaffolds or procedure; it was previously reported.Because the initial report has already been filed, this event must remain reportable.No investigation required.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
 
Event Description
Subsequent to the initial 30-day medwatch report, additional information was received.On (b)(6) 2016, the patient was found dead at home.Paramedics performed cardiopulmonary resuscitation (cpr); however, the patient could not be revived.Cause of death was listed at ischemic heart disease and right coronary artery atheroma.Secondary cause of death was listed as diabetes mellitus type 2 and chronic obstructive pulmonary disease.The study physician has deemed this event as unrelated to the study devices or study procedure.Although the patient death, due to ischemic heart disease and right coronary artery atheroma, is not related to the implanted absorb scaffolds or procedure, this event has been reported; therefore, it will remain reportable.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6839217
MDR Text Key84449231
Report Number2024168-2017-07250
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 09/25/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/01/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/30/2014
Device Catalogue Number1012463-18
Device Lot Number3073161
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/19/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ABSORB BVS 3.0X28 ASPIRIN, CLOPIDOGREL
Patient Outcome(s) Death;
Patient Age64 YR
Patient Weight66
-
-